Search
Payments_to_patienten_organisations_2016.pdf
Payments_to_patienten_organisations_2015.pdf
Payments_to_patienten_organisations_2013.pdf
Payments_to_patienten_organisations_2014.pdf
Payments_to_patienten_organisations_2017.pdf
Payments_to_patienten_organisations_2019.pdf
210324_BIAH_Corporate-Booklet_A5_Update_web.pdf
Payments_to_patienten_organisations_2020.pdf
recipe_tomato_rigatoni.pdf
What is Pharmacovigilance & its role on Patient Safet.pdf
Boehringer Ingelheim - Whitepaper High throughput cultivation platform microbial strain and process development
Boehringer Ingelheim Climate Seed Report 2022 Climate Contributions
Payments_to_patienten_organisations_2022
cancer_statistics_and_incidence_rates.pdf
Prevention-and-Treatment-of-Diabetic-and-Cardiovascular-Complications-in-Kenya.pdf
What is being done for patient safety by different stakeholder
Avenciguat (BI 685509): sGC activator | SSc
Avenciguat (BI 685509): sGC activator | SSc
Glutamate receptor modulator
Glutamate receptor modulator
Glutamate receptor modulator
What is pharmacovigilance & its role on patient safety
Early Access Treatments & Compassionate Use Programs
Explore how we facilitate patient access to investigational and/or unlicensed medicines through our individual requests and Compassionate Use programs
The Research Process
The Research Process
Chronic kidney disease is a silent killer
Living with chronic kidney disease can have drastic impacts on a patient and their family’s life. A patient and her caregiver share their story on managing it.
Living with type 2 diabetes
People living with type 2 diabetes often suffer a degree of stigma. Learn from Jurjen de Lange what it takes to live a good life despite the disease.